Found 421 matching trials
TASO-001 in Combination With Recombinant Interleukin-2(Aldesleukin) in Advanced or Metastatic Solid Tumor
PHASE1To evaluate safety, tolerance and efficacy of TASO(TGF-Ξ²2 targeting anti-se...
Location
Seoul National University Hospital
High Dose IL-2 and Stereotactic Ablative Body Radiation Therapy for Metastatic Renal Cancer
PHASE2In this i-SABR (immunotherapy + Stereotactic Ablative Body Radiation) trial...
Location
University of Texas Southwestern Medical Center
Vaccine Therapy With or Without Interleukin-2 in Treating Patients With Metastatic Melanoma
PHASE1RATIONALE: Vaccines made from white blood cells treated with antigens may m...
Location
Warren Grant Magnuson Clinical Center - NCI Clinical Studies Support
Monoclonal Antibody Therapy With Sargramostim and Interleukin-2 in Treating Children With Neuroblastoma
PHASE1Monoclonal antibodies can locate tumor cells and either kill them or delive...
Location
Children's Oncology Group
IPI Biochemotherapy for Chemonaive Patients With Metastatic Melanoma
PHASE1The goal of the Phase I part of this clinical research study is to find the...
Location
University of Texas MD Anderson Cancer Center
Genetically Engineered PBMC and PBSC Expressing NY-ESO-1 TCR After a Myeloablative Conditioning Regimen to Treat Patients With Advanced Cancer
PHASE1This phase I clinical trial evaluates the safety and feasibility of adminis...
Location
UCLA / Jonsson Comprehensive Cancer Center
FT516 in Combination With Monoclonal Antibodies in Advanced Solid Tumors
PHASE1This is a Phase 1 dose-finding study of FT-516 in combination with monoclon...
Location
University of Minnesota Masonic Cancer Center
Safety and Efficacy of BAY 50-4798 in Patients With HIV Infection
PHASE1The purpose of this study is to evaluate the safety of the experimental dru...
Location
Multiple Locations
Medroxyprogesterone or Interferon and/or Aldesleukin in Treating Patients With Metastatic Kidney Cancer
PHASE3RATIONALE: Medroxyprogesterone may help shrink or slow the growth of kidney...
Location
Multiple Locations
Gene-Modified White Blood Cells Followed By Interleukin-2 and Vaccine Therapy in Treating Patients With Metastatic Melanoma
PHASE1RATIONALE: Inserting a gene that has been created in the laboratory into a ...
Location
Warren Grant Magnuson Clinical Center - NCI Clinical Trials Referral Office